Regenerative Medicine Consortium reference material

Regenerative Medicine Consortium Reference Material

The following documents and websites provide reference material about FDA and NIH regulation of regenerative medicine.

Go back to the Regenerative Medicine Consortium

Pre-IND meetings

For information about pre-IND meetings as well as other types of regulatory meetings with the FDA, please see the following documents:


Interested parties may contact Dr. Patrick Riggins, Ph.D., Branch Chief, Regulatory Management Staff, at 301-827-5366, or Patrick.Riggins@fda.hhs.gov for any questions related to early meetings, pre-IND meetings or other types of regulatory meetings with OCTGT.

Past Presentations

FDA & NIH Website Links

Guidance documents

Advisory committee documents

Miscellaneous

 

© 2013 California Institute for Regenerative Medicine